These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29538158)

  • 1. End-of-life of implantable defibrillator: are we certain it should always be replaced?
    Stazi F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implantable cardioverter-defibrillator: An update.
    Miller JD; Yousuf O; Berger RD
    Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in implantable cardioverter-defibrillator therapy: Advancement beyond technology alone.
    Bhakta D; Foreman LD
    Trends Cardiovasc Med; 2015 Oct; 25(7):612-3. PubMed ID: 25776986
    [No Abstract]   [Full Text] [Related]  

  • 6. When to consider an implantable cardioverter defibrillator following myocardial infarction?
    Szwejkowski BR; Wright GA; Connelly DT; Gardner RS
    Heart; 2015 Dec; 101(24):1996-2000. PubMed ID: 26526420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?
    Al-Khatib SM; Gillis AM; Curtis AB
    Circulation; 2018 Jan; 137(4):317-319. PubMed ID: 29070501
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study.
    Neuzner J; Hohnloser SH; Kutyifa V; Glikson M; Dietze T; Mabo P; Vinolas X; Kautzner J; O'Hara G; Lawo T; Brachmann J; VanErven L; Gadler F; Appl U; Wang J; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1078-1085. PubMed ID: 30945798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
    Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of inappropriate shocks in young people and how to avoid them.
    Upadhyay GA; Mela T; Singh JP
    Heart; 2012 Oct; 98(19):1457-66. PubMed ID: 22965797
    [No Abstract]   [Full Text] [Related]  

  • 12. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis.
    Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo-Tcheugui JB; Martin DT; Joseph J; Singh JP
    Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009139. PubMed ID: 33554611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter-Defibrillator Failure and Currently Available Options.
    Elayi CS; Charnigo RJ; Heron PM; Lee BK; Olgin JE
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630173
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing.
    Jackson N; Viswanathan K; Cameron D; Nair K
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
    Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
    Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 10-year follow-up of a patient affected by myotonic dystrophy type 1 with implantable cardioverter-defibrillator implanted for secondary prevention.
    De Ambroggi G; Ali H; Cappato R; Sansone VA; De Ambroggi L
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):150-152. PubMed ID: 31490228
    [No Abstract]   [Full Text] [Related]  

  • 18. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
    Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improve the prevention of sudden cardiac arrest in emerging countries: the Improve SCA clinical study design.
    Zhang S; Singh B; Rodriguez DA; Chasnoits AR; Hussin A; Ching CK; Huang D; Liu YB; Cerkvenik J; Willey S; Kim YH
    Europace; 2015 Nov; 17(11):1720-6. PubMed ID: 26037794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease.
    Nishikawa T; Fujino M; Nakajima I; Asaumi Y; Kataoka Y; Anzai T; Kusano K; Noguchi T; Goto Y; Nishimura K; Miyamoto Y; Kiso K; Yasuda S
    Europace; 2017 Jul; 19(7):1153-1162. PubMed ID: 27738062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.